Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs Form Health

Eve
Graded #189

Higher grade

vs+5.699999999999996
Form Health
Graded #317

Lower grade

The verdict

Eve takes it — 66.3/100 to 60.6/100.

Eve grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEve +26
55
29
Dose & formulationEve +11
88
77
Clinical oversightForm Health +7
79
86
Labs & monitoringEven
52
52
FulfillmentForm Health +14
67
81
Contract termsEven
41
41
Eve · left barForm Health · right bar

The numbers

MetricEveForm Health
WeighScore66.3/10060.6/100
GradeCC
Scorecard rank#189#317
Semaglutide$195/mo (compounded)$1,350/mo (starting dose, brand-name)
Tirzepatide$195/mo (compounded)$1,350/mo (starting dose, brand-name)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
Eve

Graded #189 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated
Form Health

Graded #317 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

Where it loses points

  • Higher brand-name pricing only
  • Premium pricing relative to market

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard